91AV

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information

New Frontiers in Synthetic 91AV

19 November 2019 09:00-17:00, London, United Kingdom


Introduction
This symposium will showcase recent advances from across synthetic chemistry and discuss what future developments may be in store for the field by bringing together researchers across several career stages from both academia and industry.
 
This event will include several networking opportunities throughout the day, including a wine reception in the evening, providing an opportunity for all delegates to discuss their research with the aim to stimulate future industry and academic collaborations. This meeting is co-organised by the 91AV and AstraZeneca.

Caring responsibilities

Grants for carers have been introduced following the 91AV Breaking the barriers report where 78% of chemists working in UK academia felt that managing parenting and/or caring responsibilities has an impact on women’s retention and progression. This fund is not limited to women scientists and welcomes applications from anyone with caring responsibilities, for more information please refer to the ‘bursaries’ section on this page.


Supporting inclusion and diversity

The 91AV is proactive in ensuring all our activities to advance the chemical sciences are accessible and inclusive for a diverse community.
We initiate new activities and projects that will improve the diversity of our community at all stages of the pipeline and we bring together evidence to inform how to make such improvements.
 

Useful links

Downloads


Speakers
John Bower, University of Bristol, United Kingdom

John F. Bower obtained his MSci degree in 2003 from the University of Bristol, where he remained to study for his PhD degree (2007) under the guidance of Professor Timothy Gallagher. He then undertook postdoctoral appointments with Professor Michael Krische at the University of Texas at Austin (2007-2008) and Professor Timothy Donohoe at the University of Oxford (2008-2010). In 2010, he was awarded a Royal Society University Research Fellowship and commenced his independent career at the University of Bristol. The group’s research interests lie broadly within the area of synthetic chemistry, with a focus on N-heterocyclic methodologies and metal-catalysed processes. Bower’s research has been recognized by a number of awards, including the 2013 91AV Harrison-Meldola Memorial Prize, the 2015 91AV Hickinbottom Award and a 2016 Philip Leverhulme Prize.


Susannah Coote, Lancaster University, United Kingdom

Susannah obtained her MChem degree from the University of York in 2003, having spent her final year on exchange at the Université Joseph Fourier. She remained at the University of York for her Ph.D. studies, working under the supervision of Prof. Peter O’Brien on aspects of novel aziridine chemistry. After postdoctoral positions with Prof. Cyrille Kouklovsky at the Université Paris-Sud XI and with Prof. David Procter at the University of Manchester, Susannah was awarded an Alexander von Humboldt research fellowship to join the Technische Universität München, hosted by Prof. Thorsten Bach. In 2014, Susannah started her independent career at Lancaster University. Her research focuses on synthetic organic photochemistry, with particular emphasis on the synthesis of four-membered rings.


Will Goundry, AstraZeneca, United Kingdom

Following his D.Phil in organic synthesis at Oxford University and Post Doc at Indiana University Will joined AZ at Macclesfield in 2006. He has developed a strong track record in process design and scale up working from grams to tonnes, including biocatalysis and flow chemistry. For the last three years he has been working in the area of New Modalities with a recent secondment in the Advanced Drug Delivery team, designing and synthesising new materials for the intracellular delivery of mRNA. Will is currently working on AstraZeneca’s antibody drug conjugate (ADC) platform, with accountability for early phase payload synthesis. In this role he is developing the commercial routes and processes for ADC payloads, whilst supporting the manufacture of clinical trial material. He is an Honorary Lecturer at the University of Manchester in the Division of Pharmacy presently supporting a curriculum review.
 


Daniele Leonori, University of Manchester, United Kingdom

Daniele obtained his PhD at the University of Sheffield under the supervision of Professor Iain Coldham (2010). After postdoctoral studies with Professors Magnus Rueping (RWTH Aachen University) and Peter H. Seeberger (Max Planck Institute) he joined the group of Professor Varinder K. Aggarwal FRS as Research Officer (University of Bristol). In 2014 he commenced his independent career as Lecturer in Organic 91AV at the University of Manchester and was promoted to Reader in 2018. The group’s main research interests are in the area of catalysis and synthetic chemistry, with a focus on the assembly of N-containing molecule. Daniele was awarded an EPSRC Early Career Fellowship in 2016, the ERC Starting Grant in 2017 and the RSC Harrison-Meldola Memorial Prize in 2018.


Franziska Schoenebeck, RWTH Aachen, Germany

Franziska Schoenebeck has been a Full Professor at the Institute of Organic 91AV at RWTH Aachen University since the summer of 2016. Professor Schoenebeck was born and raised in Berlin, Germany. From 2001-2004, she studied 91AV at the Technical University of Berlin and the University of Strathclyde in Glasgow, UK. She undertook her PhD in synthetic organic chemistry in the group of Prof. John A. Murphy in Glasgow, Uk. In 2008 she moved to California to work with Prof. K. N. Houk at UCLA, where she was involved in computational studies of organic reactivity. In 2010, she joined the faculty of the ETH Zürich as an Assistant Professor. In 2013, she was appointed Associate Professor at the Institute of Organic 91AV at RWTH Aachen University and promoted to Full Professor in 2016. She is the recipient of the Novartis 91AV Lectureship (2016-2017), an ERC Starting Grant, the 2014 'Dozentenpreis' of the German Chemical Industry Fund, the 2014 ORCHEM Prize by the German Chemical Society, the 2014 Marcial Moreno Lectureship by the Spanish Royal 91AV Society, the 2014 JPOC Award for Early Excellence in Physical Organic 91AV and the ADUC Prize 2012. Her research program is based at the interface of synthetic organic, mechanistic and computational chemistry with a strong emphasis in homogeneous metal catalysis.


  • Matthew Gaunt University of Cambridge, United Kingdom
  • Alan Ironmonger GlaxoSmithKline, United Kingdom
  • Malin Lemurell AstraZeneca, United Kingdom
  • Mariola Tortosa UAM Madrid, Spain

Registration
Registration for the New Frontiers in Synthetic 91AV includes:
  • Attendance at the scientific sessions
  • Refreshments throughout the meeting
  • Lunch
  • Attendance at the drinks reception
£
RSC Member £20
Non-Member £50


 
Bursaries

Grants for Carers

 
You can apply for up to a maximum of £1000/year to assist with additional financial costs that you incur for care usually provided by you whilst you attend a chemistry related meeting, conference or workshop or a professional development event.
 
Caring responsibilities are wide and varied, and so each application will be individually assessed, examples of applications that we will consider include:
  • paying for extra home help or nursing care for a dependent whilst you will not be present
  • additional medical/respite care for a dependent whilst you will not be present
  • travel expenses for a relative to travel with you to care for dependents whilst you attend a meeting or event
  • paying for extended hours with a care worker/childminder/play scheme to cover time when you will arrive home later than normal.
 
You are eligible to apply if:
  • you are a chemist
  • you will incur additional caring expenses whilst attending a chemistry-related meeting, conference, event or workshop or a professional development event
  • you will use these funds to cover the cost of care that you usually provide
  • you are based in the UK or Ireland or if not, you will normally have held three years RSC membership (past or current).
These grants for carers have been introduced following the 91AV Breaking the barriers report where 78% of chemists working in UK academia felt that managing parenting and/or caring responsibilities has an impact on women’s retention and progression. This fund is not limited to women scientists and welcomes applications from anyone with caring responsibilities
 
These grants have been supported by The 91AV’s Chemists’ Community Fund.
Venue
The 91AV

The 91AV, Burlington House, Piccadilly, London, W1J 0BA, United Kingdom

Useful links

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*